| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K09344309 |
| PharmacoGx | BRD-K09344309 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TRIM39-RPP21 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | DNAJA4 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |
| mRNA | MID2 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | CPZ | CTRPv2 | pan-cancer | AAC | -0.28 | 0.05 |
| mRNA | TANGO2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | C11orf58 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | VOPP1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | SIN3B | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | PTPN23 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | SLC6A19 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
